Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Av. do Cafe S/N, 14040-903 Ribeirao Preto, SP, Brazil.
Eur J Med Chem. 2012 Aug;54:804-12. doi: 10.1016/j.ejmech.2012.06.042. Epub 2012 Jun 28.
The bioactive naphtoquinone lapachol was studied in vitro by a biomimetic model with Jacobsen catalyst (manganese(III) salen) and iodosylbenzene as oxidizing agent. Eleven oxidation derivatives were thus identified and two competitive oxidation pathways postulated. Similar to Mn(III) porphyrins, Jacobsen catalyst mainly induced the formation of para-naphtoquinone derivatives of lapachol, but also of two ortho-derivatives. The oxidation products were used to develop a GC-MS (SIM mode) method for the identification of potential phase I metabolites in vivo. Plasma analysis of Wistar rats orally administered with lapachol revealed two metabolites, α-lapachone and dehydro-α-lapachone. Hence, the biomimetic model with a manganese salen complex has evidenced its use as a valuable tool to predict and elucidate the in vivo phase I metabolism of lapachol and possibly also of other bioactive natural compounds.
生物活性萘醌拉帕醇在 Jacobsen 催化剂(锰(III)席夫碱)和碘苯作为氧化剂的仿生模型中进行了体外研究。因此鉴定了 11 种氧化衍生物,并提出了两种竞争的氧化途径。与 Mn(III)卟啉类似,Jacobsen 催化剂主要诱导拉帕醇的对-萘醌衍生物的形成,但也诱导了两种邻-衍生物的形成。氧化产物被用于开发 GC-MS(SIM 模式)方法,以鉴定体内潜在的 I 相代谢物。用 lapachol 口服给药的 Wistar 大鼠的血浆分析显示出两种代谢物,α-拉帕酮和脱氢-α-拉帕酮。因此,锰席夫碱配合物的仿生模型已证明其可用作预测和阐明拉帕醇体内 I 相代谢的有价值的工具,也可能是其他生物活性天然化合物的工具。